3 Takeaways From FDA's Off-Label Forum Plan
The U.S. Food and Drug Administration's surprise announcement Wednesday of a two-day forum on its oversight of off-label promotion contained intriguing glimpses into the agency's thinking and suggests that policy changes...To view the full article, register now.
Already a subscriber? Click here to view full article